Uncomplicating the futureSM
 
Search

Healthcare Professionals

   Print page  Email page

Adhesions and Your OBGYN Practice

Uterus adhesions
Dense adhesions to the uterus

Adhesions are a common consequence of pelvic surgery, forming after 46%–65% of primary C-sections1-3 and after up to 95% of gynecologic laparotomies.4 Adhesions can lead to serious complications for patients, including infertility4, chronic pelvic pain5, and small bowel obstruction.6

Adhesions also complicate and prolong future surgeries by making it difficult to identify, reach, and separate tissues including the uterus, tubes, and ovaries.7 Adhesions can also limit and complicate future treatment options, including intraperitoneal chemotherapy7, radiotherapy8, and laparoscopy.7

Adhesions account for up to:

  • 40% of infertility cases4
  • 48% of chronic pelvic pain cases9
  • 75% of small bowel obstructions10

SEPRAFILM® Adhesion Barrier is proven to help prevent postoperative adhesions.11

SEPRAFILM can be applied during the following open procedures11:

  • C-section (Learn more, including application techniques)
  • Hysterectomy (Learn more, including application techniques)
  • Myomectomy (Learn more, including application techniques)
  • Pelvic floor resection
  • Exploratory laparotomy
  • Adhesiolyisis
  • Adnexal procedures
10. Scovill WA. Small bowel obstruction. In: Cameron JL, ed. Current Therapy in Surgery. St Louis, MO: Mosby Yearbook Medical Publishers, Inc; 1995:100-104.
 
11. SEPRAFILM Prescribing Information. Cambridge, MA: Genzyme Biosurgery; 2007.
 
11. SEPRAFILM Prescribing Information. Cambridge, MA: Genzyme Biosurgery; 2007.
 
1. Lyell DJ, Caughey AB, Hu E, Daniels K. Peritoneal closure at primary Cesarean delivery and adhesions. Obstet Gynecol. 2005;106:275-80.
2. Morales KJ, Gordon MC, Bates GW Jr. Postcesarean delivery adhesions associated with delayed delivery of infant. Am J Obstet Gynecol. 2007;196:461.e1-461.e6.
3. Fushiki H, Ikoma T, Kobayashi H, Yoshimoto H. Efficacy of SEPRAFILM as an Adhesion Barrier in Cesarean Sections. Obstetric and Gynecological Treatment [Japanese]. 2005;91(5):557-561.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
5. Keltz MD, Gera PS, Olive DL.  Prospective randomized trial of right-sided paracolic adhesiolysis for chronic pelvic pain. JSLS. 2006;10(4):443-446.
 
6. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al.  Adhesion-related hospital readmissions after abdominal and pelvic surgery:  a retrospective cohort study.Lancet1999;353(9163):1476-1480.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
8. Eifel PF.  Radiation therapy. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 119-161.
 
9. Stovall TG, Elder RF, Ling FW. Predictors of pelvic adhesions. J Reprod Med. 1989; 34:345-348.
 

 

Dr Stamos
Surgeons discuss
adhesions and their potential impact on patients
Aimee's Success Story
Aimee's Story
See what patients say about SEPRAFILM
 

Important Safety Information

Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy. The type and frequency of adverse events reported are consistent with events typically seen following surgery when used as directed. Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events. For important safety information, please see package insert.

Terms and Conditions of Use | Privacy Policy | Contact Us | This site is intended for United States residents only © 2002-2008 Genzyme Corporation. All rights reserved. Seprafilm and Genzyme are registered trademarks of Genzyme Corporation. genzyme logo